3h
Investor's Business Daily on MSNMerck's Biggest Moneymaker Could Get Even Bigger. But Will It Help Downtrodden Shares?The FDA is due to make an approval decision on injectable Keytruda by mid-September. The move could bolster downtrodden Merck stock.
For higher-risk multiple myeloma (MM), successful patient selection and monitoring strategies are vital for the management of adverse events and the disease itself.
Ireland's first medically supervised injecting facility in Dublin is regarded as a dream come true for intravenous drug users ...
Trail and Greater RCMP officers responded to a report of intravenous drug use outside of a cannabis dispensary in Trail last week.
A study shows how hemodialysis helped save the life of a horse a horse with an often deadly form of toxicosis.
STEQEYMA® (ustekinumab-stba) is Celltrion's biosimilar to STELARA® (ustekinumab), which was launched on March 12, 2025 ...
Intra-arterial thrombolysis via urokinase following reperfusion by endovascular thrombectomy for stroke does not affect survival without disability.
Hospitals are using AI to predict supply chain disruptions and make the best use of supplies before they expire.
Pleco Therapeutics BV has held a successful pre-IND meeting with the FDA to discuss the continued development of PTX-252, an intravenous formulation designed to treat patients with acute myeloid ...
Oregon State University scientists have developed a highly efficient, uniquely shaped magnetic nanoparticle that could enable ...
CMS is extending the 2024 merit-based incentive payment system deadline and reopening the extreme and uncontrollable ...
Artificial intelligence can improve intravenous nutrition for premature babies, a Stanford Medicine study has shown. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results